These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Implantable transvenous cardioverter-defibrillators. Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144 [TBL] [Abstract][Full Text] [Related]
3. Late complications in patients with pectoral defibrillator implants with transvenous defibrillator lead systems: high incidence of insulation breakdown. Mehta D; Nayak HM; Singson M; Chao S; Pe E; Camuñas JL; Gomes JA Pacing Clin Electrophysiol; 1998 Oct; 21(10):1893-900. PubMed ID: 9793085 [TBL] [Abstract][Full Text] [Related]
4. Incidence of ICD lead related complications during long-term follow-up: comparison of epicardial and endocardial electrode systems. Korte T; Jung W; Spehl S; Wolpert C; Moosdorf R; Manz M; Lüderitz B Pacing Clin Electrophysiol; 1995 Nov; 18(11):2053-61. PubMed ID: 8552520 [TBL] [Abstract][Full Text] [Related]
5. Transvenous defibrillation leads: high incidence of failure during long-term follow-up. Dorwarth U; Frey B; Dugas M; Matis T; Fiek M; Schmoeckel M; Remp T; Durchlaub I; Gerth A; Steinbeck G; Hoffmann E J Cardiovasc Electrophysiol; 2003 Jan; 14(1):38-43. PubMed ID: 12625608 [TBL] [Abstract][Full Text] [Related]
6. [High incidence of isolator fractures in transvenous implantation of cardioverter defibrillators]. Mewis C; Kühlkamp V; Dörnberger V; Mermi J; Seipel L Z Kardiol; 1997 Feb; 86(2):85-94. PubMed ID: 9173702 [TBL] [Abstract][Full Text] [Related]
7. Oversensing in a cardioverter defibrillator system caused by interaction between two endocardial defibrillation leads in the right ventricle. Pfitzner P; Trappe HJ Pacing Clin Electrophysiol; 1998 Apr; 21(4 Pt 1):764-8. PubMed ID: 9584310 [TBL] [Abstract][Full Text] [Related]
8. [Lead-related complications in 340 patients with an implantable cardiverter/defibrillator]. Schwacke H; Drögemüller A; Siemon G; Werling C; Saggau W; Senges J; Seidl K Z Kardiol; 1999 Aug; 88(8):559-65. PubMed ID: 10506392 [TBL] [Abstract][Full Text] [Related]
9. [Complications in transvenous and transvenous-subcutaneous implantable defibrillator systems]. Podczeck A; Hief C; Veit F; Jakl G; Kaltenbrunner W; Nürnberg M; Frohner K; Steinbach K Z Kardiol; 1994 May; 83(5):366-72. PubMed ID: 8053246 [TBL] [Abstract][Full Text] [Related]
10. Sensing/pacing lead complications with a newer generation implantable cardioverter-defibrillator: worldwide experience from the Guardian ATP 4210 clinical trial. Stambler BS; Wood MA; Damiano RJ; Greenway PS; Smutka ML; Ellenbogen KA J Am Coll Cardiol; 1994 Jan; 23(1):123-32. PubMed ID: 8277070 [TBL] [Abstract][Full Text] [Related]
11. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Kleemann T; Becker T; Doenges K; Vater M; Senges J; Schneider S; Saggau W; Weisse U; Seidl K Circulation; 2007 May; 115(19):2474-80. PubMed ID: 17470696 [TBL] [Abstract][Full Text] [Related]
12. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator. Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011 [TBL] [Abstract][Full Text] [Related]
13. Implantable cardioverter defibrillator lead placement in the middle cardiac vein after tricuspid valve surgery. Lopez JA Europace; 2012 Jun; 14(6):853-8. PubMed ID: 22333241 [TBL] [Abstract][Full Text] [Related]
14. Lead fracture in cephalic versus subclavian approach with transvenous implantable cardioverter defibrillator systems. Gallik DM; Ben-Zur UM; Gross JN; Furman S Pacing Clin Electrophysiol; 1996 Jul; 19(7):1089-94. PubMed ID: 8823837 [TBL] [Abstract][Full Text] [Related]
15. Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications. Ellenbogen KA; Wood MA; Shepard RK; Clemo HF; Vaughn T; Holloman K; Dow M; Leffler J; Abeyratne A; Verness D J Am Coll Cardiol; 2003 Jan; 41(1):73-80. PubMed ID: 12570948 [TBL] [Abstract][Full Text] [Related]
16. [Inadequate therapeutic effects of implantable cardioverter/defibrillators: etiology, therapy and prevention]. Mattke S; Dorwarth U; Müller D; Hoffmann E; Markewitz A; Kaulbach H; Schmöckel M; Steinbeck G Z Kardiol; 1994 May; 83(5):359-65. PubMed ID: 8053245 [TBL] [Abstract][Full Text] [Related]
17. A modified subcutaneous implantable cardioverter-defibrillator implant in a patient with a previous left ventricular epicardial defibrillation patch. Mehta PA; Bostock J; Rinaldi CA Europace; 2012 Jan; 14(1):149-50. PubMed ID: 21873629 [TBL] [Abstract][Full Text] [Related]
18. Limitations and late complications of third-generation automatic cardioverter-defibrillators. Nunain SO; Roelke M; Trouton T; Osswald S; Kim YH; Sosa-Suarez G; Brooks DR; McGovern B; Guy M; Torchiana DF Circulation; 1995 Apr; 91(8):2204-13. PubMed ID: 7697850 [TBL] [Abstract][Full Text] [Related]
19. [Problems and complications after implantation of automatic defibrillators]. Trappe HJ; Klein H; Fieguth HG; Wenzlaff P; Lichtlen PR Med Klin (Munich); 1993 Nov; 88(11):619-28. PubMed ID: 8295602 [TBL] [Abstract][Full Text] [Related]
20. Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management. Olde Nordkamp LR; Brouwer TF; Barr C; Theuns DA; Boersma LV; Johansen JB; Neuzil P; Wilde AA; Carter N; Husby M; Lambiase PD; Knops RE Int J Cardiol; 2015 Sep; 195():126-33. PubMed ID: 26026928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]